The Latest Cardiac and Vascular News
New Imaging Technology to Improve Coronary Artery Disease Patient Outcomes BEDFORD, Mass., Oct. 9, 2020 /PRNewswire/ — SpectraWAVE, Inc., a development-stage medical imaging company focused on improving coronary artery disease (CAD) outcomes with photonics, is pleased to announce that Eman Namati, Ph.D., has been appointed Chief Executive Officer. Dr. Namati brings more than a […]
Avail has designed the only end-to-end system that helps surgical teams in operating rooms collaborate with remote medical experts for live procedures and clinical training PALO ALTO, Calif.–(BUSINESS WIRE)–Avail Medsystems, the medical technology company pioneering telemedicine for the procedure room (“Procedural TelemedicineTM”), today announced that it has raised $100 million […]
Company ranks as a top employer in the state of Pennsylvania where its corporate headquarters are located WAYNE, Pa., Oct. 08, 2020 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX), has been recognized as part of Forbes’ annual list of America’s Best-In-State Employers 2020. The company ranked #6 out of 100 […]
$17.8 million in proceeds will fund clinical development of innovative devices to treat peripheral artery diseases (PAD) such as CLI MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–R3 Vascular Inc. today announced closing of its Series A financing round, including new equity investments of $15 million and the conversion of $2.8 million of convertible notes. […]
Visionary leaders with proven experience commercializing technologies around the globe bring strategic insight to the company’s board of directors to accelerate growth and innovation PARIS and BOSTON, Oct. 7, 2020 /PRNewswire/ — Cardiologs, a global leader in artificial intelligence (AI) for cardiac diagnostics, announced today that it has appointed two veteran medical device industry executives […]
BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced it has entered into a non-exclusive royalty-bearing license agreement with Abbott Laboratories (NYSE: ABT), the global healthcare company. The non-exclusive license grants Abbott access to Quanterix’ portfolio of bead-based technology […]
CALGARY, Alberta, Oct. 06, 2020 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX:RVX) announced today that it has entered into a definitive stock purchase agreement for a private placement of 10,560,000 equity units at a price of $1.25 per unit for gross proceeds of $13.2 million (US$10 million). […]
TEL AVIV, Israel, Oct. 06, 2020 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR) (“Company”), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease (CAD), today announced the appointment of Patrick Jamnik as vice president, business development and strategic initiatives. […]
WESTMINSTER, Colo., Oct. 05, 2020 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today announced the promotion of Debra Marshall, MD, FACC to Chief Medical Officer, and Sharon Perry, RAC, to Vice President, Regulatory Affairs and […]
ENGLEWOOD, Colo., Oct. 6, 2020 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced the lease of a new 50,488 square foot warehouse facility for its growing manufacturing and inventory requirements. […]
